Composition for preventing, alleviating or treating cancer
AssigneeCkp Therapeutics, Inc.
InventorsKi Cheong Park, Seokmo Kim
Life of this patent
Estimating the term…
Abstract
A compound represented by Formula 1 according to the present disclosure, when used in combination with an anticancer drug, may significantly improve the anticancer effect of the anticancer drug, and may induce the same anticancer effect even when the anticancer drug is used in a significantly smaller amount than the conventionally used amount, thereby reducing the side effects caused by administration of the anticancer drug. Furthermore, the compound represented by Formula 1 makes it possible to effectively prevent, alleviate or treat either anticancer-resistant cancer or cancer which recurs or metastasizes after anticancer drug treatment.
Claims13
A pharmaceutical composition for enhancing sensitivity to an anticancer drug or for co-administration with the anticancer drug, the pharmaceutical composition containing, as an active ingredient, 1-(2-fluorophenyl)-4,6-dimethyl-1H,2H,3H-pyrrolo[3,2-c]quinoline represented by the following Formula 1 or a pharmaceutically acceptable salt thereof:
A pharmaceutical composition for overcoming or inhibiting anticancer drug resistance, the pharmaceutical composition containing, as an active ingredient, 1-(2-fluorophenyl)-4,6-dimethyl-1H,2H,3H-pyrrolo[3,2-c]quinoline represented by the following Formula 1 or a pharmaceutically acceptable salt thereof:
A pharmaceutical composition for preventing or treating cancer, the pharmaceutical composition containing, active ingredients:
- 1-(2-fluorophenyl)-4,6-dimethyl-1H,2H,3H-pyrrolo[3,2-c]quinoline represented by the following Formula 1 or a pharmaceutically acceptable salt thereof;
- and an anticancer drug:
Dependencies are inferred from the claim text.